With regard to metastases, tumors with loss of p21 expression tended to show increased frequency of lymphatic invasion (P = 0.089, Table 1) and a significantly higher frequency of lymph node metastasis (P = 0.022, Table 2) than p21-expressing tumors. This evidence concerns the gene CDKN1A and metastatic malignant neoplasm in the lymph nodes.